Endothelin Receptor Antagonists Plus Sodium-Glucose Cotransporter 2 Inhibitors: Poster Child for a New ERA of Combination Therapies?

J Am Soc Nephrol. 2024 Oct 1;35(10):1306-1308. doi: 10.1681/ASN.0000000000000487. Epub 2024 Sep 4.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Drug Therapy, Combination*
  • Endothelin Receptor Antagonists* / therapeutic use
  • Humans
  • Renal Insufficiency, Chronic / drug therapy
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Endothelin Receptor Antagonists